Model
Edge
Halozyme Therapeutics, Inc.
0001662521
Filing Type
4
Filing Date
4/28/2024
Updated
4/29/24, 3:51 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership